Create an account to get unlimited access
Sign Up

Probiotics Supplementation for The Prevention of Atopic Dermatitis in Children by Dr Emma King

Webinars
Probiotics Supplementation For The Prevention Of Atopic Dermatitis In Children By Dr Emma King Probiotics Supplementation For The Prevention Of Atopic Dermatitis In Children By Dr Emma King
Tags
  • Probiotics
  • Atopic dermatitis occurs as a result of a reaction in the skin. The reaction leads to ongoing itching, swelling and redness. Atopic dermatitis is most common in infants and it may start as early as at the age of 2 to 6 months.
  • In this webinar, Dr. Emma King from the Royal Children’s Hospital in Australia provides a review and meta-analysis on ‘Probiotic supplementation for the prevention of atopic dermatitis in children’, tackling the use of probiotics in pregnancy, breastfeeding mothers and infancy and their role in the prevention of this health issue.
This webinar is presented to you by
Biostime Institute for Nutrition and Care
View Here
Other topic of interest
Hmo Shaping
HMOs: Shaping the Infant’s Healthy Gut Microbiota
Publications
Probiotics
What Are Probiotics?
Publications
From Lab Bench To Formulated Ingredient Characterization Production And Commercialization Of Human Milk Oligosaccharides From Lab Bench To Formulated Ingredient Characterization Production And Commercialization Of Human Milk Oligosaccharides
From Lab Bench to Formulated Ingredient: Characterization, Production, And Commercialization of Human Milk Oligosaccharides
Publications
2 Fucosyllactose Inhibits Imiquimod Induced Psoriasis In Mice By Regulating Th17 Cell Response Via The Stat3 Signaling Pathway 2 Fucosyllactose Inhibits Imiquimod Induced Psoriasis In Mice By Regulating Th17 Cell Response Via The Stat3 Signaling Pathway
2'-Fucosyllactose Inhibits Imiquimod-Induced Psoriasis in Mice By Regulating Th17 Cell Response Via The Stat 3 Signaling Pathway
Publications
A Combination Of 2 Fucosyllactose And Osteopontin Attnuates 2 4 Dinitrochlorobenzene Dncb Induced Contact Dermatitis Murine Model A Combination Of 2 Fucosyllactose And Osteopontin Attnuates 2 4 Dinitrochlorobenzene Dncb Induced Contact Dermatitis Murine Model
A Combination Of 2'fucosyllactose And Osteopontin Attenuates 2,4 - Dinitrochlorobenzene (Dncb)- Induced Contact Dermatitis Murine Model
Publications
Community Driven Metabolism Of Human Milk Oligosaccharides By A Consortia Of Bifidobacteria Spp Community Driven Metabolism Of Human Milk Oligosaccharides By A Consortia Of Bifidobacteria Spp
Community Driven Metabolism of Human Milk Oligosaccharides by A Consortia of Bifidobacteria Spp
Publications
Integration of Human Milk Oligosaccharide Utilisation Pathways in An Infant Bifidobacterial Community by Intergrated Genomics and Proteomics
Publications
Xiang Cohort Study An Association Of Breast Milk Composition With Maternal Bmi And Infant Growth During The First Three Months Of Life Xiang Cohort Study An Association Of Breast Milk Composition With Maternal Bmi And Infant Growth During The First Three Months Of Life
Xian Cohort Study: An Association of Breast Milk Composition with Maternal BMI And Infant Growth During the First Three Months of Life
Publications
Maternal Health Maternal Health
Influence of postpartum depression and probiotic treatment on maternal brain serotonin and caregiving behaviours
Publications
Prebiotic for Infants and Children
Publications
Probiotics And Prebiotics In Allergy Probiotics And Prebiotics In Allergy
Probiotics and Prebiotics in Allergy
Publications
Biostime Introducing Solids Better
Introducing Solids Better
Webinars Summary
Biostime Supporting Immunity Through Optimal Microbiome Development Biostime Supporting Immunity Through Optimal Microbiome Development
Supporting Immunity through Optimal Microbiome Development
Webinars Summary
Biostime The Role Of The Microbiome And Health Trajectory Biostime The Role Of The Microbiome And Health Trajectory
The Role of the Microbiome and Health Trajectory
Webinars Summary
Biostime Targeting The Microbiome In Paediatric Disease Biostime Targeting The Microbiome In Paediatric Disease
Targeting the Microbiome in Paediatric Disease of the Intestine and Beyond
Webinars Summary
Biostime Human Milk Oligosaccharides Protein Infant Formula Headhbanner Biostime Human Milk Oligosaccharides Protein Infant Formula Headhbanner
Human Milk Oligosaccharides and Protein in Infant Formula and Health Outcomes
Webinars Summary
Resource Center Detail Page Webniars Hmos The Frontier Of Infant Nutrition And Health Resource Center Detail Page Webniars Hmos The Frontier Of Infant Nutrition And Health
HMOs The Frontier of Infant Nutrition and Health by Prof. Ardythe Morrow
Webinars
Could Breasmilk Set The Child On A Path With No Allergy Could Breasmilk Set The Child On A Path With No Allergy
Could Breastmilk Set the Child on A Path with No Allergy? By Prof. Valerie Verhasselt
Webinars
Cow's Milk Allergy: Clinical Symptoms and Efficacy of Prevention and Treatments Cow's Milk Allergy: Clinical Symptoms and Efficacy of Prevention and Treatments
Cow’s Milk Allergy by Prof. Christophe Dupont
Webinars
Webinar Dha And Ara Infant Feeding How They Came To Be Regarded As Conditionally Essentia Webinar Dha And Ara Infant Feeding How They Came To Be Regarded As Conditionally Essentia
DHA And Ara Infant Feeding: How They Came to Be Regarded as Conditionally Essential?
Webinars
The Role Of Osteopontin In Infant Health By Profbolonnerdal The Role Of Osteopontin In Infant Health By Profbolonnerdal
The Role of Osteopontin In Infant Health by Prof. Bo Lonnerdal
Webinars
What is SN-2 Palmitate?
Publications
Next Up

Are you a Healthcare Professional?

Important Notice and Declaration

Breast milk is best for babies. Professional advice should be followed before using an infant formula. Introducing partial bottle feeding could negatively affect breast feeding. Good maternal nutrition is important for breast feeding and reversing a decision not to breast feed may be difficult. Infant formula should always be used as directed. Proper use of an infant formula is important to the health of the infant. Social and financial implications should be considered when selecting a method of feeding.

The information provided on this website is intended for use by healthcare professionals only. It is a condition of use of this site that you are a healthcare professional within the meaning of regulations within your country of practice. Then denoting below Yes I am/No icons. For Healthcare Professionals based in Australia : It is a condition of use of this site that you are a healthcare professional within the meaning of the Marketing in Australia of Infant Formulas (MAIF) Agreement or the Therapeutic Goods Act.

Yes, I amNo